{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:59:51Z","timestamp":1777561191009,"version":"3.51.4"},"reference-count":67,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T00:00:00Z","timestamp":1553817600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,3,29]]},"DOI":"10.3233\/jad-181144","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T12:07:16Z","timestamp":1550837236000},"page":"571-582","source":"Crossref","is-referenced-by-count":25,"title":["Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer\u2019s Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis"],"prefix":"10.1177","volume":"68","author":[{"given":"Ann","family":"Tiiman","sequence":"first","affiliation":[{"name":"Department of Clinical Neuroscience (CNS), Center for Molecular Medicine CMM L8:01, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesna","family":"Jeli\u0107","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Care Sciences and Society (NVS), Division of Clinical Geriatrics, Karolinska Institutet, Huddinge, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcri","family":"Jarvet","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Biophysics, Arrhenius Laboratories, Stockholm University, Stockholm, Sweden"},{"name":"The National Institute of Chemical Physics and Biophysics, Tallinn, Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petter","family":"J\u00e4remo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Vrinnevi Hospital, Norrk\u00f6ping, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nenad","family":"Bogdanovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Care Sciences and Society (NVS), Division of Clinical Geriatrics, Karolinska Institutet, Huddinge, Sweden"},{"name":"Department of Geriatric Medicine, University of Oslo, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Rigler","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry and Biophysics (MBB), Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Terenius","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience (CNS), Center for Molecular Medicine CMM L8:01, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Gr\u00e4slund","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Biophysics, Arrhenius Laboratories, Stockholm University, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladana","family":"Vukojevi\u0107","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience (CNS), Center for Molecular Medicine CMM L8:01, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-181144_ref1","volume-title":"World Alzheimer Report 2016. Improving healthcare for people living with dementia: Coverage, quality and costs now and in the future","author":"Prince","year":"2016"},{"key":"10.3233\/JAD-181144_ref2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jalz.2017.02.001","article-title":"2017 Alzheimer\u2019s disease facts and figures","volume":"13","author":"Alzheimer\u2019s Association","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181144_ref3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-181144_ref4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/ijch.201600105","article-title":"The amyloid-\u03b2 peptide in amyloid formation processes: Interactions with blood proteins and naturally occurring metal ions","volume":"57","author":"Wallin","year":"2017","journal-title":"Israel J Chem"},{"key":"10.3233\/JAD-181144_ref5","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1021\/acs.biochem.5b00976","article-title":"Heterogeneity and turnover of intermediates during amyloid-beta (Abeta) peptide aggregation studied by fluorescence correlation spectroscopy","volume":"54","author":"Tiiman","year":"2015","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-181144_ref6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0003-2697(89)90046-8","article-title":"Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1","volume":"177","author":"Naiki","year":"1989","journal-title":"Anal Biochem"},{"key":"10.3233\/JAD-181144_ref7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","article-title":"Quantification of beta-sheet amyloid fibril structures with thioflavin T","volume":"309","author":"LeVine","year":"1999","journal-title":"Methods Enzymol"},{"key":"10.3233\/JAD-181144_ref8","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","article-title":"Molecular mechanism of Thioflavin-T binding to amyloid fibrils","volume":"1804","author":"Biancalana","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-181144_ref9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.dyepig.2014.05.004","article-title":"Photophysical study of Thioflavin T as a fluorescence marker of amyloid fibrils","volume":"110","author":"Freire","year":"2014","journal-title":"Dyes Pigm"},{"key":"10.3233\/JAD-181144_ref10","doi-asserted-by":"crossref","first-page":"14042","DOI":"10.1039\/C5CC04256A","article-title":"Ultrafast fluorescence spectroscopy reveals a dominant weakly-emissive population of fibril bound thioflavin-T","volume":"51","author":"Singh","year":"2015","journal-title":"Chem Commun (Camb)"},{"key":"10.3233\/JAD-181144_ref11","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1021\/acs.analchem.5b02747","article-title":"High fluorescence anisotropy of Thioflavin T in aqueous solution resulting from its molecular rotor nature","volume":"88","author":"Kuznetsova","year":"2016","journal-title":"Anal Chem"},{"key":"10.3233\/JAD-181144_ref12","doi-asserted-by":"crossref","first-page":"16863","DOI":"10.1073\/pnas.1002867107","article-title":"Protein-induced photophysical changes to the amyloid indicator dye thioflavin T","volume":"107","author":"Wolfe","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-181144_ref13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12017-008-8035-0","article-title":"Maximizing the potential of plasma amyloid-beta as a diagnostic biomarker for Alzheimer\u2019s disease","volume":"10","author":"Oh","year":"2008","journal-title":"Neuromolecular Med"},{"key":"10.3233\/JAD-181144_ref14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/alzrt162","article-title":"Plasma amyloid beta measurements - a desired but elusive Alzheimer\u2019s disease biomarker","volume":"5","author":"Toledo","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-181144_ref15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jalz.2016.09.014","article-title":"Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic","volume":"13","author":"O\u2019Bryant","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181144_ref16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40120-017-0073-9","article-title":"A review of fluid biomarkers for Alzheimer\u2019s disease: Moving from CSF to blood","volume":"6","author":"Blennow","year":"2017","journal-title":"Neurol Ther"},{"key":"10.3233\/JAD-181144_ref17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13311-016-0481-z","article-title":"Biomarkers for the early detection and progression of Alzheimer\u2019s disease","volume":"14","author":"Counts","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.3233\/JAD-181144_ref18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.dadm.2016.03.002","article-title":"Detection of Alzheimer\u2019s disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers","volume":"3","author":"DeMarshall","year":"2016","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-181144_ref19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7555\/JBR.30.20150131","article-title":"Autoantibodies in Alzheimer\u2019s disease: Potential biomarkers, pathogenic roles, and therapeutic implications","volume":"30","author":"Wu","year":"2016","journal-title":"J Biomed Res"},{"key":"10.3233\/JAD-181144_ref20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-017-0162-3","article-title":"Tau PET imaging: Present and future directions","volume":"12","author":"Saint-Aubert","year":"2017","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-181144_ref21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neurobiolaging.2016.03.033","article-title":"Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer\u2019s disease in the context of a structured 5-phase development framework","volume":"52","author":"Garibotto","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-181144_ref22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neurobiolaging.2016.07.012","article-title":"Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer\u2019s disease in the context of a structured 5-phase development framework","volume":"52","author":"Chiotis","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-181144_ref23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/15622970310029912","article-title":"CSF markers for Alzheimer\u2019s disease: Total tau, phospho-tau and Abeta42","volume":"4","author":"Andreasen","year":"2003","journal-title":"World J Biol Psychiatry"},{"key":"10.3233\/JAD-181144_ref24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/acn3.160","article-title":"CSF beta-amyloid 1-42 - what are we measuring in Alzheimer\u2019s disease?","volume":"2","author":"Hu","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.3233\/JAD-181144_ref25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JAD-140771","article-title":"Amyloid-beta 42\/40 cerebrospinal fluid concentration ratio in the diagnostics of Alzheimer\u2019s disease: Validation of two novel assays","volume":"43","author":"Lewczuk","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-181144_ref26","doi-asserted-by":"crossref","first-page":"18176","DOI":"10.1073\/pnas.0809250105","article-title":"Quantitative single-molecule imaging by confocal laser scanning microscopy","volume":"105","author":"Vukojevic","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-181144_ref27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1034\/j.1600-0854.2001.21107.x","article-title":"Fluorescence correlation spectroscopy measures molecular transport in cells","volume":"2","author":"Elson","year":"2001","journal-title":"Traffic"},{"key":"10.3233\/JAD-181144_ref28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00018-004-4305-7","article-title":"Study of molecular events in cells by fluorescence correlation spectroscopy","volume":"62","author":"Vukojevic","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JAD-181144_ref29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbrc.2010.04.070","article-title":"Fluorescence and single molecule analysis in cell biology","volume":"396","author":"Rigler","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-181144_ref30","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.bpj.2011.11.012","article-title":"Fluorescence correlation spectroscopy: Past, present, future","volume":"101","author":"Elson","year":"2011","journal-title":"Biophys J"},{"key":"10.3233\/JAD-181144_ref31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/B978-0-12-388422-0.00002-9","article-title":"Brief introduction to fluorescence correlation spectroscopy","volume":"518","author":"Elson","year":"2013","journal-title":"Methods Enzymol"},{"key":"10.3233\/JAD-181144_ref32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00249-017-1271-1","article-title":"Fluorescence-based monitoring of electronic state and ion exchange kinetics with FCS and related techniques: From T-jump measurements to fluorescence fluctuations","volume":"47","author":"Rigler","year":"2018","journal-title":"Eur Biophys J"},{"key":"10.3233\/JAD-181144_ref33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2017.11.005","article-title":"Introduction to fluorescence correlation spectroscopy-Brief and simple","volume":"140-141","author":"Elson","year":"2018","journal-title":"Methods"},{"key":"10.3233\/JAD-181144_ref34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-510X(97)00221-9","article-title":"Aggregation of amyloid beta-protein as function of age and apolipoprotein E in normal and Alzheimer\u2019s serum","volume":"154","author":"Chauhan","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-181144_ref35","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.clinbiochem.2009.10.010","article-title":"Thioflavin T fluorescence in human serum: Correlations with vascular health and cardiovascular risk factors","volume":"43","author":"Griffin","year":"2010","journal-title":"Clin Biochem"},{"key":"10.3233\/JAD-181144_ref36","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid beta-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain","volume":"66","author":"Tapiola","year":"2009","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-181144_ref37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00401-012-1046-9","article-title":"Localization of cholesterol, amyloid and glia in Alzheimer\u2019s disease transgenic mouse brain tissue using time-of-flight secondary ion mass spectrometry (ToF-SIMS) and immunofluorescence imaging","volume":"125","author":"Sole-Domenech","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-181144_ref38","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1021\/acschemneuro.5b00324","article-title":"Single-molecule imaging of individual amyloid protein aggregates in human biofluids","volume":"7","author":"Horrocks","year":"2016","journal-title":"ACS Chem Neurosci"},{"key":"10.3233\/JAD-181144_ref39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12154-009-0027-5","article-title":"Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status","volume":"3","author":"Groenning","year":"2010","journal-title":"J Chem Biol"},{"key":"10.3233\/JAD-181144_ref40","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.semnuclmed.2012.07.001","article-title":"Development of positron emission tomography beta-amyloid plaque imaging agents","volume":"42","author":"Mathis","year":"2012","journal-title":"Semin Nucl Med"},{"key":"10.3233\/JAD-181144_ref41","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.nucmedbio.2011.10.007","article-title":"Preclinical studies of potential amyloid binding PET\/SPECT ligands in Alzheimer\u2019s disease","volume":"39","author":"Svedberg","year":"2012","journal-title":"Nucl Med Biol"},{"key":"10.3233\/JAD-181144_ref42","first-page":"255","volume-title":"Positron Emission Tomography: Current Clinical and Research Aspects","author":"Svedberg","year":"2012"},{"key":"10.3233\/JAD-181144_ref43","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.1073\/pnas.1218402110","article-title":"Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism","volume":"110","author":"Cohen","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-181144_ref44","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/j.1742-4658.2010.07571.x","article-title":"Amyloid oligomers: Spectroscopic characterization of amyloidogenic protein states","volume":"277","author":"Lindgren","year":"2010","journal-title":"FEBS J"},{"key":"10.3233\/JAD-181144_ref45","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1021\/bi5003579","article-title":"Alzheimer peptides aggregate into transient nanoglobules that nucleate fibrils","volume":"53","author":"Luo","year":"2014","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-181144_ref46","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1074\/jbc.A116.714576","article-title":"Cross-interactions between the Alzheimer disease amyloid-beta peptide and other amyloid proteins. A further aspect of the amyloid cascade hypothesis","volume":"292","author":"Luo","year":"2017","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-181144_ref47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jim.2012.02.011","article-title":"Single molecule enzyme-linked immunosorbent assays: Theoretical considerations","volume":"378","author":"Chang","year":"2012","journal-title":"J Immunol Methods"},{"key":"10.3233\/JAD-181144_ref48","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nbt.1641","article-title":"Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations","volume":"28","author":"Rissin","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.3233\/JAD-181144_ref49","doi-asserted-by":"crossref","first-page":"e66381","DOI":"10.1371\/journal.pone.0066381","article-title":"Evaluating amyloid-beta oligomers in cerebrospinal fluid as a biomarker for Alzheimer\u2019s disease","volume":"8","author":"Holtta","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-181144_ref50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.dadm.2016.05.005","article-title":"Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders","volume":"3","author":"Andreasson","year":"2016","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-181144_ref51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-beta biomarkers for Alzheimer\u2019s disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.3233\/JAD-181144_ref52","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jbio.201400145","article-title":"An infrared sensor analysing label-free the secondary structure of the Abeta peptide in presence of complex fluids","volume":"9","author":"Nabers","year":"2016","journal-title":"J Biophotonics"},{"key":"10.3233\/JAD-181144_ref53","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1021\/acs.analchem.5b04286","article-title":"Amyloid-beta-secondary structure distribution in cerebrospinal fluid and blood measured by an immuno-infrared-sensor: A biomarker candidate for Alzheimer\u2019s disease","volume":"88","author":"Nabers","year":"2016","journal-title":"Anal Chem"},{"key":"10.3233\/JAD-181144_ref54","doi-asserted-by":"crossref","first-page":"e8763","DOI":"10.15252\/emmm.201708763","article-title":"Amyloid blood biomarker detects Alzheimer\u2019s disease","volume":"10","author":"Nabers","year":"2018","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-181144_ref55","first-page":"227","article-title":"Factors affecting the antigen-antibody reaction","volume":"5","author":"Reverberi","year":"2007","journal-title":"Blood Transfus"},{"key":"10.3233\/JAD-181144_ref56","first-page":"45","volume-title":"Advances in Immunoassay Technology","author":"Schiettecatte","year":"2012"},{"key":"10.3233\/JAD-181144_ref57","first-page":"299","volume-title":"Trends in Immunolabelled and Related Techniques","author":"Saiki","year":"2012"},{"key":"10.3233\/JAD-181144_ref58","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jneumeth.2010.12.001","article-title":"Specificity and sensitivity of the Abeta oligomer ELISA","volume":"195","author":"Klaver","year":"2011","journal-title":"J Neurosci Methods"},{"key":"10.3233\/JAD-181144_ref59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12952-017-0066-3","article-title":"Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?","volume":"16","author":"Hunter","year":"2017","journal-title":"J Negat Results Biomed"},{"key":"10.3233\/JAD-181144_ref60","doi-asserted-by":"crossref","first-page":"41929","DOI":"10.1038\/srep41929","article-title":"SpotLight Proteomics: Uncovering the hidden blood proteome improves diagnostic power of proteomics","volume":"7","author":"Lundstrom","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-181144_ref61","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1152\/ajplung.00301.2003","article-title":"Proteomics: Current techniques and potential applications to lung disease","volume":"287","author":"Hirsch","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.3233\/JAD-181144_ref62","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/14789450.2017.1384697","article-title":"Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer\u2019s disease: An update","volume":"14","author":"Portelius","year":"2017","journal-title":"Expert Rev Proteomics"},{"key":"10.3233\/JAD-181144_ref63","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.410370414","article-title":"Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer\u2019s disease: Inverse correlation with severity of dementia and effect of apolipoprotein E genotype","volume":"37","author":"Nitsch","year":"1995","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-181144_ref64","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3233\/JAD-2009-1214","article-title":"Increased total tau but not amyloid-beta(42) in cerebrospinal fluid correlates with short-term memory impairment in Alzheimer\u2019s disease","volume":"18","author":"Lin","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-181144_ref65","doi-asserted-by":"crossref","first-page":"26801","DOI":"10.1038\/srep26801","article-title":"Plasma beta-amyloid in Alzheimer\u2019s disease and vascular disease","volume":"6","author":"Janelidze","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-181144_ref66","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jalz.2018.03.005","article-title":"Estimation of lifetime risks of Alzheimer\u2019s disease dementia using biomarkers for preclinical disease","volume":"14","author":"Brookmeyer","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181144_ref67","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: An updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-181144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:09:15Z","timestamp":1777370955000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-181144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,29]]},"references-count":67,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-181144","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,29]]}}}